Chiome Bioscience Inc. reported non-consolidated earnings results for the fiscal year ended December 31, 2016. For the period, the company reported net sales of JPY 252 million against JPY 280 million a year ago. Operating loss was JPY 1,042 million against JPY 1,269 million a year ago. Ordinary loss was JPY 1,047 million against JPY 1,253 million a year ago. Net loss was JPY 1,491 million against JPY 1,282 million a year ago. Net loss per share was JPY 65.91 against JPY 58.29 a year ago. Negative return on equity was 32.9% compared to 24.8% a year ago. Loss before income taxes was JPY 1,501.280 million against JPY 1,280.695 million a year ago. Net cash used in operating activities was JPY 969.906 million against JPY 1,245.325 million a year ago. Purchase of property and equipment was JPY 10.455 million against JPY 163.789 million a year ago. Purchase of intangible assets was JPY 0.500 million against JPY 4.265 million a year ago.